Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Metter

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reports|November 1, 1979
DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristineG J Hill, G E Metter, E T Krementz, et al.
Cancer Treatment Reports|January 1, 1977
Phase II study of 5-azacytidine in solid tumorsA J Weiss, G E Metter, T F Nealon, et al.
Cancer Treatment Reports|March 1, 1978
Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumorsS J Altman, G E Metter, T F Nealon, et al.
Journal of Surgical Oncology|January 1, 1978
Adriamycin, bleomycin, and CCNU as effective induction chemotherapeutic agents in advanced squamous cell carcinoma (COG Protocol 7333)J P Scarborough, G E Metter, H Stephens Moseley, et al.
Transplantation Proceedings|February 1, 1987
A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisoneS J Forman, K G Blume, R A Krance, et al.
Cancer Treatment Reports|May 1, 1976
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065)R D Carter, E T Krementz, G J Hill, et al.
Blood|July 1, 1983
Malignant lymphoma, mixed cell type, diffuseB N Nathwani, G E Metter, R A Gams, et al.
Human Pathology|May 1, 1987
Mitotic counts in follicular lymphomasD J Ellison, B N Nathwani, G E Metter, et al.
Blood|October 1, 1986
What should be the morphologic criteria for the subdivision of follicular lymphomas?B N Nathwani, G E Metter, T P Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical StudiesG E Metter, B N Nathwani, J S Burke, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reports|November 1, 1979
DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristineG J Hill, G E Metter, E T Krementz, et al.
Cancer Treatment Reports|January 1, 1977
Phase II study of 5-azacytidine in solid tumorsA J Weiss, G E Metter, T F Nealon, et al.
Cancer Treatment Reports|March 1, 1978
Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumorsS J Altman, G E Metter, T F Nealon, et al.
Journal of Surgical Oncology|January 1, 1978
Adriamycin, bleomycin, and CCNU as effective induction chemotherapeutic agents in advanced squamous cell carcinoma (COG Protocol 7333)J P Scarborough, G E Metter, H Stephens Moseley, et al.
Transplantation Proceedings|February 1, 1987
A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisoneS J Forman, K G Blume, R A Krance, et al.
Cancer Treatment Reports|May 1, 1976
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065)R D Carter, E T Krementz, G J Hill, et al.
Blood|July 1, 1983
Malignant lymphoma, mixed cell type, diffuseB N Nathwani, G E Metter, R A Gams, et al.
Human Pathology|May 1, 1987
Mitotic counts in follicular lymphomasD J Ellison, B N Nathwani, G E Metter, et al.
Blood|October 1, 1986
What should be the morphologic criteria for the subdivision of follicular lymphomas?B N Nathwani, G E Metter, T P Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical StudiesG E Metter, B N Nathwani, J S Burke, et al.
Pageof 3